PD1/PD-L1 pathway in psoriasis and psoriatic arthritis: a review

By M. Adamczyk, D. Krasowska. 2021

Subfields: Dermatology, Immunology, Rheumatology

Citations in the corpus

• Heterogeneity of PD-L1 Expression Between the Primary Tumor and Matched Lymph Node Metastases in Head and Neck Squamous Cell Carcinomas (2026, unknown): “…PD-L1 signaling has been implicated in the pathogenesis of inflammatory skin disorders, including psoriasis, atopic dermatitis, and cutaneous lupus erythematosus, where altered expression on keratinocytes and infiltrating immune cells contributes to the breakdown of peripheral tolerance [33].”